Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Retrospective analysis of the clinical utility of multi-cytokine profiles in smear-negative pulmonary tuberculosis

Xuemei Li, Weidong Zhao, Hong Han, Zhi Yang, Fengqing Bi and Yingchun He
Saudi Medical Journal July 2024, 45 (7) 658-666; DOI: https://doi.org/10.15537/smj.2024.45.7.20240310
Xuemei Li
From the Department of Clinical Laboratory (Li, Han, Yang, Bi, He), First Affiliated Hospital of Dali University; from the Department of Clinical Laboratory (Zhao), School of Clinical Medicine, Dali University, Dali, Yunnan, China; and from the Department of Clinical Laboratory (Zhao), Second Infectious Disease Hospital of Yunnan Province, Dali, Yunnan, China.
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weidong Zhao
From the Department of Clinical Laboratory (Li, Han, Yang, Bi, He), First Affiliated Hospital of Dali University; from the Department of Clinical Laboratory (Zhao), School of Clinical Medicine, Dali University, Dali, Yunnan, China; and from the Department of Clinical Laboratory (Zhao), Second Infectious Disease Hospital of Yunnan Province, Dali, Yunnan, China.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Han
From the Department of Clinical Laboratory (Li, Han, Yang, Bi, He), First Affiliated Hospital of Dali University; from the Department of Clinical Laboratory (Zhao), School of Clinical Medicine, Dali University, Dali, Yunnan, China; and from the Department of Clinical Laboratory (Zhao), Second Infectious Disease Hospital of Yunnan Province, Dali, Yunnan, China.
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi Yang
From the Department of Clinical Laboratory (Li, Han, Yang, Bi, He), First Affiliated Hospital of Dali University; from the Department of Clinical Laboratory (Zhao), School of Clinical Medicine, Dali University, Dali, Yunnan, China; and from the Department of Clinical Laboratory (Zhao), Second Infectious Disease Hospital of Yunnan Province, Dali, Yunnan, China.
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fengqing Bi
From the Department of Clinical Laboratory (Li, Han, Yang, Bi, He), First Affiliated Hospital of Dali University; from the Department of Clinical Laboratory (Zhao), School of Clinical Medicine, Dali University, Dali, Yunnan, China; and from the Department of Clinical Laboratory (Zhao), Second Infectious Disease Hospital of Yunnan Province, Dali, Yunnan, China.
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yingchun He
From the Department of Clinical Laboratory (Li, Han, Yang, Bi, He), First Affiliated Hospital of Dali University; from the Department of Clinical Laboratory (Zhao), School of Clinical Medicine, Dali University, Dali, Yunnan, China; and from the Department of Clinical Laboratory (Zhao), Second Infectious Disease Hospital of Yunnan Province, Dali, Yunnan, China.
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yingchun He
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    - Diagnostic value of four cytokines alone or in combination for the smear-negative pulmonary tuberculosis. A) The receiver operating characteristic (ROC) curve of Interferons (IFN)-α, interleukin (IL)-2, IL-10, and IL-8. B) represents the ROC curve of the combination of IFN-α, IL-2, IL-10, and IL-8 for diagnosing smear-negative pulmonary tuberculosis. AUC: area under curve

Tables

  • Figures
    • View popup
    Table 1

    - Demographic and clinical characteristics of TB and non-TB groups.

    CharacteristicsTB (n=77)Non-TB (n=48)P-value
    Age, median (IQR)53 (40, 64)59 (46, 67)0.266
    Gender, n (%)0.175
    Male48 (62.3%)24 (50.0%)
    Female29 (37.7%)24 (50.0%)
    BMI, mean ± SD20.11 ± 3.5323.46 ± 4.50<0.001
    WBC (×109/L), median (IQR)7.11 (5.42, 8.67)5.89 (4.64, 7.79)0.027
    Neutrophil (%), median (IQR)72.2 (66.0, 77.4)59.6 (50.1, 70.2)<0.001
    Monocyte (%), median (IQR)8.7 (6.6, 11.0)8.0 (6.3, 9.1)0.042
    ESR (mm/h), median (IQR)59 (21.5, 96.8)27.5 (12.0, 57.0)0.002
    CRP (ng/mL), median (IQR)29.21 (6.53, 59.46)3.26 (1.27, 21.00)<0.001
    IL-5, median (IQR)2.36 (1.41, 3.32)1.94 (1.58, 3.165)0.392
    IFN-a, median (IQR)1.40 (0.88, 2.06)1.22 (0.89, 1.63)0.161
    IL-2, median (IQR)1.41 (1.04, 1.85)1.18 (0.86, 1.52)0.027
    IL-6, median (IQR)12 (6.4, 25.46)3.01 (1.50, 4.94)<0.001
    IL-1b, median (IQR)5.17 (1.95, 10.26)3.25 (1.39, 8.10)0.087
    IL-10, median (IQR)1.68 (1.25, 4.09)1.39 (1.08, 2.31)0.079
    IFN-g, median (IQR)15.02 (5.47, 32.03)4.46 (1.99, 6.3)<0.001
    IL-8, median (IQR)6.44 (1.8, 26.19)4.05 (0.85, 9.34)0.023
    IL-17, median (IQR)2.68 (1.00, 7.20)2.72 (1.63, 13.02)0.195
    IL-4, median (IQR)1.36 (0.69, 1.90)1.19 (1.00, 1.62)0.471
    IL-12p70, median (IQR)1.36 (0.80, 1.85)1.48 (1.05, 1.87)0.575
    TNF-α, median (IQR)1.99 (1.09, 5.29)1.41 (0.82, 3.16)0.110
    IGRA positive, n (%)68 (88.3%)14 (29.2%)<0.001

    Chi-square for gender, t test for body mass index (BMI), Wilcoxon test for others. SD: standard deviation, IQR: interquartile, TB: tuberculosis, IL: interlukin, TNF-α: tumor necrosis factor-alpha, IGRA: interferon gamma release assay test, WBC: white blood cells, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein

      • View popup
      Table 2

      - Demographic and clinical characteristics of smear-negative pulmonary tuberculosis (SNPT) and smear-positive pulmonary tuberculosis (SPPT) groups.

      CharacteristicsSNPT (n=42)SPPT (n=35)P-value
      Age, mean±standard deviation53.6 ± 14.750.7 ± 17. 90.432
      Gender, n (%)0.699
      Male27 (35.1%)21 (27.3%)
      Female15 (19.5%)14 (18.2%)
      BMI, median (IQR)20.4 (17.3, 22.1)18.9 (17.8, 22.5)0.943
      ESR (mm/h), median (IQR)42.5 (12.5, 95)70.5 (47.75, 99.75)0.091
      CRP (ng/mL), median (IQR)27.36 (5.87, 55.83)34.29 (9.95, 65.39)0.563
      WBC (×109/L), median (IQR)6.64 (5.09, 7.77)7.67 (6.57, 9.35)0.056
      Neutrophil (%), median (IQR)72.55 (65.2, 77.7)71.9 (66, 77.4)0.747
      Monocyte (%), mean ± SD8.7 ± 3.89.5 ± 3.20.319
      IL-5, median (IQR)2.83 (1.51, 4.22)2.09 (1.35, 2.83)0.104
      IFN-a, median (IQR)1.9 (1.09, 3.03)1.2 (0.74, 1.59)<0.001
      IL-2, median (IQR)1.66 (1.17, 2.44)1.22 (0.9, 1.48)0.012
      IL-6, median (IQR)11.44(6.44, 25.49)12.44 (6.06, 22.96)0.963
      IL-1b, median (IQR)7.86 (2.38, 13.9)3.32 (1.88, 5.71)0.032
      IL-10, median (IQR)2.17 (1.47, 4.6)1.53 (1.06, 1.88)0.005
      IFN-g, median (IQR)14.87 (7.44, 39.89)15.02 (3.84, 28.50)0.385
      IL-8, median (IQR)15.82 (1.99, 51.78)3 (1.00, 8.40)0.003
      IL-17, median (IQR)4.28 (1.44, 8.46)1.89 (0.89, 3.29)0.074
      IL-4, median (IQR)1.43 (0.64, 1.89)1.34 (0.87, 1.89)0.771
      IL-12P70, median (IQR)1.61 (0.92, 1.95)1.12 (0.74, 1.75)0.060
      TNF-a, median (IQR)2.81 (1.09, 5.66)1.7 (1.06, 3.51)0.231
      IGRA positive, n (%)34 (81.0%)34 (97.1%)0.015

      Chi-square test for gender and IGRA positive proportion, t test for age and monocyte, Wilcoxon test for others. BMI: body mass index, IQR: interquartile, IL: interlukin, TNF-α: tumor necrosis factor-alpha, IGRA: interferon gamma release assay test, WBC: white blood cells, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein

        • View popup
        Table 3

        - Effect size of cytokine levels in smear-negative pulmonary tuberculosis (SNPT) and smear-positive pulmonary tuberculosis (SPPT) population.

        CharacteristicsSNPT (n=42)SPPT (n=35)Effect sizeP-value
        IL-5, median (IQR)2.83 (1.51, 4.22)2.09 (1.35, 2.83)0.35 (-0.11-0.80)0.104
        IFN-a, median (IQR)1.90 (1.09, 3.03)1.20 (0.74, 1.59)0.59 (0.13-1.05)<0.001
        IL-2, median (IQR)1.66 (1.17, 2.44)1.22 (0.90, 1.48)0.61 (0.15-1.07)0.012
        IL-6, median (IQR)11.44(6.44, 25.49)12.44 (6.06, 22.96)0.12 (-0.33-0.57)0.963
        IL-1b, median (IQR)7.86 (2.38, 13.9)3.32 (1.88, 5.71)0.37 (-0.08-0.83)0.032
        IL-10, median (IQR)2.17 (1.47, 4.6)1.53 (1.06, 1.88)0.62 (0.17-1.08)0.005
        IFN-g, median (IQR)14.87 (7.44, 39.89)15.02 (3.84, 28.50)0.19 (-0.26-0.64)0.385
        IL-8, median (IQR)15.82 (1.99, 51.78)3.00 (1.00, 8.40)0.76 (0.29-1.22)0.003
        IL-17, median (IQR)4.28 (1.44, 8.46)1.89 (0.89, 3.29)0.03 (-0.42-0.48)0.074
        IL-4, median (IQR)1.43 (0.64, 1.89)1.34 (0.87, 1.89)0.01 (-0.45-0.45)0.771
        IL-12P70, median (IQR)1.61 (0.92, 1.95)1.12 (0.74, 1.75)0.36 (-0.09-0.82)0.060
        TNF-a, median (IQR)2.81 (1.09, 5.66)1.70 (1.06, 3.51)-0.03 (-0.48-0.42)0.231
        IGRA positive, n (%)34 (81.0%)34 (97.1%)NA0.015

        NA: not analyzed. Effect sizes were calculated using the Cohen d. Absolute values of 0.20–0.49 represent a small change; values of 0.50–0.79 a medium change; and values of ≥0.80 a large change. IQR: interquartile, IL: interlukin, TNF-α: tumor necrosis factor-alpha, IGRA: interferon gamma release assay test, WBC: white blood cells

          • View popup
          Table 4

          - Receiver operating characteristic analysis of cytokine levels in (SNPT) and smear-positive pulmonary tuberculosis (SPPT) population.

          CytokinesAUC (95%CI)Cut-offYouden valueP-valueSensitivitySpecificityPPVNPV
          IFN-a (pg/mL)0.734 (0.623-0.844)1.910.414<0.00191.4%50.0%87.5%60.4%
          IL-2 (pg/mL)0.668 (0.546-0.790)1.550.3670.00977.1%59.5%75.8%36.7%
          IL-10 (pg/mL)0.686 (0.564-0.809)2.060.405<0.00185.7%54.8%82.1%61.2%
          IL-8 (pg/mL)0.698 (0.580-0.816)9.460.395<0.00180.0%59.5%90.5%58.9%
          IFN-a+ IL-2+IL-10+IL-80.759 (0.652-0.865)-0.443<0.00180.0%64.2%79.4%65.1%

          CI: confidence interval, PPV: positive predictive value, NPV: negative predictive value, AUC: area under curve

          PreviousNext
          Back to top

          In this issue

          Saudi Medical Journal: 45 (7)
          Saudi Medical Journal
          Vol. 45, Issue 7
          1 Jul 2024
          • Table of Contents
          • Cover (PDF)
          • Index by author
          Print
          Download PDF
          Email Article

          Thank you for your interest in spreading the word on Saudi Medical Journal.

          NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

          Enter multiple addresses on separate lines or separate them with commas.
          Retrospective analysis of the clinical utility of multi-cytokine profiles in smear-negative pulmonary tuberculosis
          (Your Name) has sent you a message from Saudi Medical Journal
          (Your Name) thought you would like to see the Saudi Medical Journal web site.
          Citation Tools
          Retrospective analysis of the clinical utility of multi-cytokine profiles in smear-negative pulmonary tuberculosis
          Xuemei Li, Weidong Zhao, Hong Han, Zhi Yang, Fengqing Bi, Yingchun He
          Saudi Medical Journal Jul 2024, 45 (7) 658-666; DOI: 10.15537/smj.2024.45.7.20240310

          Citation Manager Formats

          • BibTeX
          • Bookends
          • EasyBib
          • EndNote (tagged)
          • EndNote 8 (xml)
          • Medlars
          • Mendeley
          • Papers
          • RefWorks Tagged
          • Ref Manager
          • RIS
          • Zotero
          Share
          Retrospective analysis of the clinical utility of multi-cytokine profiles in smear-negative pulmonary tuberculosis
          Xuemei Li, Weidong Zhao, Hong Han, Zhi Yang, Fengqing Bi, Yingchun He
          Saudi Medical Journal Jul 2024, 45 (7) 658-666; DOI: 10.15537/smj.2024.45.7.20240310
          Twitter logo Facebook logo Mendeley logo
          • Tweet Widget
          • Facebook Like
          • Google Plus One
          Bookmark this article

          Jump to section

          • Article
            • Abstract
            • Methods
            • Results
            • Discussion
            • Acknowledgment
            • Footnotes
            • References
          • Figures & Data
          • eLetters
          • References
          • Info & Metrics
          • PDF

          Related Articles

          • No related articles found.
          • PubMed
          • Google Scholar

          Cited By...

          • No citing articles found.
          • Google Scholar

          More in this TOC Section

          • Psychological stress and its association with bronchial asthma in Saudi Arabia
          • The factors affecting comfort and the comfort levels of patients hospitalized in the coronary intensive care unit
          • Exploring communication challenges with children and parents among pharmacists in Saudi Arabia
          Show more Original Article

          Similar Articles

          Keywords

          • Mycobacterium tuberculosis
          • smear-negative pulmonary tuberculosis
          • cytokine profiles
          • retrospective analysis

          CONTENT

          • home

          JOURNAL

          • home

          AUTHORS

          • home
          Saudi Medical Journal

          © 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

          Powered by HighWire